| | |

Atomic Show #246 – Carmen Bigles, Coqui Pharmaceuticals Update

ByRod Adams
Coqui rendering

In November 2014, I spoke with Carmen Bigles, the founder of Coqui Pharmaceuticals, a company that is preparing to build a $330 million medical isotope production facility near Gainesville, FL.

Since that discussion 11 months ago, Coqui has made steady progress in completing their construction and operating license application to the NRC for a class 104 license to build two medical isotope reactors.

They have also made considerable progress in the design of their production and administrative facilities.

Carmen and I got together on a call for an update this morning. You can hear the excitement in her voice as her company’s plans take shape and approach reality. Coqui is working with some highly qualified partner companies, including MPR Associates for engineering and license preparation, INVAP for reactor design and licensing support, Gresham, Smith and Partners for architectural design and Hogan Lovells US, LLP for legal/regulatory advice and consulting.

Though the license application has not yet been submitted to the NRC, it is in the final stages of preparation and should be finalized during the first half of 2016. Ms. Bigles is planning a big party to celebrate that milestone.

I hope you enjoy our conversation and agree that Coqui should a terrific employer for nuclear professionals in a couple of years.

Play

Podcast: Play in new window | Download (Duration: 31:44 — 29.2MB)

Subscribe: RSS

Rod Adams
Rod Adams

Rod Adams is Managing Partner of Nucleation Capital, a venture fund that invests in advanced nuclear, which provides affordable access to this clean energy sector to pronuclear and impact investors. Rod, a former submarine Engineer Officer and founder of Adams Atomic Engines, Inc., which was one of the earliest advanced nuclear ventures, is an atomic energy expert with small nuclear plant operating and design experience. He has engaged in technical, strategic, political, historic and financial analysis of the nuclear industry, its technology, regulation, and policies for several decades through Atomic Insights, both as its primary blogger and as host of The Atomic Show Podcast. Please click here to subscribe to the Atomic Show RSS feed. To join Rod's pronuclear network and receive his occasional newsletter, click here.

Similar Posts

  • Atomic Show #269 – Robert Bryce, A Question of Power

    ByRod Adams

    In the modern world, countries need a reliable electricity grid to prosper. Globally, demand for electricity is growing as a result of population growth, new ways to use electricity, and the effort to spread access to electrical power to a greater portion of the world’s population. For the past four years, Robert Bryce has been…

  • Atomic Show #239 – Sarah Laskow and the LNT model

    ByRod Adams

    In March 2015, Foreign Policy magazine published an article by Sarah Laskow titled The Mushroom Cloud and The X-Ray Machine. The article described the controversy over the radiation protection model known as the linear, no-threshold dose response. Ms. Laskow conducted some admirable literature research and talked with a number of well-known people. The ones that…

  • Nuclear plant construction in U.K. will gain momentum from Brexit vote

    ByRod Adams

    British voters have spoken; they want to leave the EU by a margin of 52% to 48%. The split should provide a boost for the UK’s nuclear energy program. It should also improve the UK’s energy resiliency and improve the effectiveness of its effort to reduce CO2 emissions. As an island nation, the UK doesn’t…

  • Atomic Show #171 – Fukushima retrospective dated March 14, 2011

    ByRod Adams

    In the near term aftermath of The Great East Japan Earthquake, Amelia Timers of The Energy Collective asked Dan Yurman, who blogs at Idaho Samizdat and ANS Nuclear Cafe and me to join her for a discussion about the events that were happening at the Fukushima Daiichi nuclear station. She and the staff had developed…